Abstract
530P - Comparative efficacy of first-line ceritinib and alectinib in advanced ALK+ NSCLC: A cross-study indirect comparison
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date